Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2019-08-23 Chen Timothy Yung-Cheng Director Sale −286 $143.01 $41K 7,614
2019-08-23 Chen Timothy Yung-Cheng Director Sale −6,700 $145.08 $972K 914
2019-08-23 Chen Timothy Yung-Cheng Director Sale −200 $146.36 $29K 714
2019-08-23 Chen Timothy Yung-Cheng Director Sale −714 $145.30 $104K 0
2019-08-23 Chen Timothy Yung-Cheng Director Exercise or conversion · Share Option (Right to Buy) +102,700 357,926
2019-08-12 Glazer Donald W. Director Other disposition −13,384 0
2019-08-12 Glazer Donald W. Director Other disposition −26,100 3,711,426
2019-08-12 Huang Jane CMO, Hematology Exercise or conversion +2,500 $45.31 $113K 2,500
2019-08-12 Huang Jane CMO, Hematology Sale −800 $132.47 $106K 1,700
2019-08-12 Huang Jane CMO, Hematology Sale −400 $134.34 $54K 1,300
2019-08-12 Huang Jane CMO, Hematology Sale −800 $135.86 $109K 500
2019-08-12 Huang Jane CMO, Hematology Sale −500 $136.91 $68K 0
2019-08-12 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) +32,500 850,465
2019-07-29 Huang Jane CMO, Hematology Exercise or conversion +5,000 $45.31 $227K 5,000
2019-07-29 Huang Jane CMO, Hematology Exercise or conversion +5,130 $29.49 $151K 10,130
2019-07-29 Huang Jane CMO, Hematology Sale −2,500 $132.83 $332K 7,630
2019-07-29 Huang Jane CMO, Hematology Sale −7,630 $135.10 $1.0M 0
2019-07-29 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) +65,000 882,965
2019-07-29 Huang Jane CMO, Hematology Exercise or conversion · Share Option (Right to Buy) +66,690 1,044,775
2019-07-08 OYLER JOHN Chief Executive Officer Sale −1,200 $125.59 $151K 1,906

Page 100 of 123 · 2,455 trades